Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02058953 · ClinicalTrials.gov registry record
CNS and Extracranial Tumor Tissues, CSF, and Blood From Patients With Melanoma Brain Metastases
A clinical trial of Melanoma and Brain Metastases, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 7
- Enrollment target
- 3
- Study locations
NCT02058953 is a study of Melanoma and Brain Metastases that has completed, run by University of Pittsburgh. The registered enrollment target is 7 participants, below the 707-participant average among 266 other Melanoma trials with a reported enrollment target (99% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT02058953, a study of Melanoma and Brain Metastases, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 7 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to collect and bank samples of blood and tissues (such as brain tissue or lymph nodes), as well as cerebrospinal fluid (CSF), which is the fluid that bathes and cushions the spinal cord. The investigator will analyze DNA biomarkers in the samples. The investigator hopes that by studying the biomarkers, he can develop tests in the future that can detect central nervous system (CNS) metastasis in blood samples before they show up on x-ray and develop medicines that can specifically target CNS metastasis.
Conditions Studied
Interventions
- PROCEDURE Craniotomy scheduled
- PROCEDURE Collection for non-craniotomy
Study Locations (3)
Pennsylvania
- University of Pittsburgh Medical Center- Hillman Cancer Center - Pittsburgh
Texas
- The University of Texas- MD Anderson Cancer Center - Houston
Other
- Melanoma Institute Australia- Westmead Institute for Cancer Research - Sydney
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2014-08-12 |
| Est. Completion | 2019-08-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02058953
The ClinicalTrials.gov registry entry for NCT02058953 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 707-participant average among 266 other Melanoma trials with a reported enrollment target (99% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Melanoma appearing as the primary indexed condition, and to 2 interventions - of which Craniotomy scheduled is the first listed.
NCT02058953 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Pennsylvania, Texas, Other.
Frequently Asked Questions
What is clinical trial NCT02058953 about?
NCT02058953 is a clinical study titled "CNS and Extracranial Tumor Tissues, CSF, and Blood From Patients With Melanoma Brain Metastases". The purpose of this study is to collect and bank samples of blood and tissues (such as brain tissue or lymph nodes), as well as cerebrospinal fluid (CSF), which is the fluid that bathes and cushions the spinal cord. The investigator will analyze DNA biomarkers in the samples. The investigator hopes ...
What is the current status of trial NCT02058953?
This trial is currently completed. The enrollment target is 7 participants. The study started on 2014-08-12. Estimated completion is 2019-08-19.
What conditions does trial NCT02058953 study?
This clinical trial studies the following conditions: Melanoma, Brain Metastases.
What interventions are being tested in trial NCT02058953?
The interventions under investigation include: Craniotomy scheduled (PROCEDURE), Collection for non-craniotomy (PROCEDURE).
Who is sponsoring clinical trial NCT02058953?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02058953 being conducted?
This trial has 3 study locations across Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Melanoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
RECRUITING · NA
-
Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
RECRUITING · Phase 2
-
Dabrafenib and/or Trametinib Rollover Study
RECRUITING · Phase 4
-
Neoadjuvant Immune Checkpoint Blockade + a Prebiotic Food-enriched Dietary Intervention to Optimize Immune Response in Melanoma: NEO-PreFED
RECRUITING · Phase 2
-
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
RECRUITING · Phase 1
-
A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.